🔎︎
An analysis in JAMA Network Open, examining new international obesity criteria, reveals substantial implications for managed care organizations and treatment coverage policies. The study, evaluating over 300,000 participants from the All of Us cohort, demonstrates that adopting updated definitions could fundamentally reshape eligibility criteria and resource-allocation strategies for pharmacotherapy.
The research found that 68.6% of participants met obesity criteria under the new framework compared to 42.9% using traditional BMI measurements. Among those currently eligible for obesity pharmacotherapy under existing insurance criteria, 51.2% would not qualify as having clinical obesity requiring treatment under the new guidelines. Conversely, 22.2% of individuals with clinical obesity would not meet current BMI-based thresholds for medication coverage, creating potential coverage gaps and administrative challenges for payers.
The new classification system introduces complexity by categorizing obesity as clinical or preclinical based on the presence of organ dysfunction. Clinical obesity affected 36.1 percent of the total population, with prevalence increasing dramatically with age, reaching 54.4 percent among adults over 70. This age distribution has important effects on Medicare. It could double the number of people in this age group who are eligible for treatment, and it will also require a review of the current criteria for prior authorization and formulary management strategies.
Cost containment efforts may benefit from the framework's risk stratification approach, as individuals with clinical obesity demonstrated substantially higher risks of diabetes, cardiovascular events, and mortality compared to those with preclinical obesity. The data suggest that targeting interventions toward clinical obesity cases could optimize resource utilization while improving health outcomes. Nonetheless, significant implementation challenges persist, necessitating investment in provider education, modifications to electronic health records, and the creation of new coverage determination protocols that include anthropometric measurements beyond BMI.
